Kurita invests in Cyclopure and secures U.S. rights to DEXSORB for PFAS treatment and regeneration

Kurita Water Industries Ltd. has completed an investment in Cyclopure Inc. and expanded a commercial partnership that grants Kurita exclusive rights to sell Cyclopure’s DEXSORB adsorbent for industrial and certain municipal water applications in the United States. The transaction accompanies operational collaboration: Kurita America is conducting technical evaluations for system integration and is responsible for design, construction, and commissioning of regeneration equipment for a planned Michigan facility intended to regenerate spent DEXSORB and concentrate captured PFAS for subsequent destruction.

DEXSORB is described by Cyclopure as a beta-cyclodextrin–based adsorbent derived from plant-sourced precursors; the material operates through host–guest complexation mechanisms characteristic of cyclodextrin chemistry. Cyclodextrin is a cyclic oligosaccharide, classifiable within polymeric carbohydrate materials, and DEXSORB has been engineered to provide selective affinity for a range of per- and polyfluoroalkyl substances (PFAS). Supplier material claims include operational stability across varying natural organic matter (NOM) loads, resistance to interference from common inorganic ions, pH robustness, and the capability for in situ regeneration with resultant PFAS mass concentration in the spent stream.

From a systems engineering perspective, Kurita’s scope includes integrating DEXSORB into packaged and engineered treatment trains for drinking water, industrial wastewater, and groundwater applications. Key technical deliverables referenced in the partnership include media loading characteristics, influent/effluent concentration dynamics at low ng/L levels, hydraulic design for fixed-bed adsorption units, regeneration cycle parameters, and handling and concentration systems for spent media. The Michigan regeneration plant is planned to accept spent media, perform regeneration to restore adsorptive capacity, and produce a concentrated PFAS waste stream intended for destruction by downstream thermal or chemical treatment providers.

Several compliance and intellectual property considerations may be relevant to practitioners reviewing the arrangement. The U.S. Environmental Protection Agency’s 2024 drinking water standards establishing 4 ng/L thresholds for PFOA and PFOS create operational targets that may influence design margins, monitoring frequency, and reporting obligations. Concentration and off‑gassing of PFAS during regeneration, residuals management, and transport of concentrated waste could implicate hazardous waste classification, manifesting, and treatment authorization under federal and state frameworks. The DEXSORB mark is noted as a registered trademark, and the underlying beta-cyclodextrin polymer chemistry may be subject to patent claims, process know‑how, and licensing terms that may affect market exclusivity and freedom‑to‑operate analyses.

For manufacturers and compliance specialists, the transaction may warrant attention to specifications for media manufacture, chain‑of‑custody protocols for regenerated media distribution, and quality control parameters for polymer-based adsorbents. Materials science aspects such as polymer backbone stability, leachables from plant-derived matrices, and lifecycle impacts of adsorbent manufacture and disposal may be material to procurement and regulatory submissions.

Legal, regulatory, and IP professionals supporting water utilities, industrial operators, or technology vendors may find the Kurita–Cyclopure collaboration of interest where project delivery, regulatory approvals, and contractual allocation of responsibilities for regeneration and waste destruction are involved. Each of these areas may merit further review in the context of project-specific requirements.

Disclaimer: This article was generated or assisted by artificial intelligence and has been reviewed for accuracy; however, AI-generated content may contain errors or omissions. This article is provided by Innov8 Chem LLC and its subsidiaries for informational purposes only. The content herein does not constitute legal, technical, or professional advice and should not be relied upon as such. This publication is not intended to endorse, promote, disparage, or harm any company, product, or service mentioned. Readers should consult qualified legal and technical professionals before making any decisions based on the information presented. Innov8 Chem LLC and its subsidiaries disclaim all liability arising from the use of or reliance on this content.

Leave a comment

Your email address will not be published. Required fields are marked *